Amplify Treatments, Testing and Advancements ETF logo

Amplify Treatments, Testing and Advancements ETFNYSE American: GERM

Profile

Assets class:

Equity

Assets under management:

$9 M

Average volume:

$2 K

Domicile:

US

Expense ratio:

0.68%

Inception date:

18 June 2020

Website:

-

Last dividends:

27 June 2024

Next dividends:

N/A

Top countries

Name
Weight
United States
81.88 %
Germany
7.02 %
United Kingdom
5.47 %
China
3.83 %
France
0.92 %
Japan
0.89 %

Dividend yield TTM

$0.098.80%

What is GERM ETF?

Under normal circumstances, the fund invests at least 80% of its net assets in U.S.-listed equity securities or ADRs of Treatments, Testing and Advancements Companies. In general, the index seeks to be comprised of companies performing advancements in research, development, and commercialization of treatments or vaccines for infectious diseases, or engaged in the advancement of research, development, manufacturing, and provision of biological tests for patients. The fund is non-diversified.

What is GERM assets class?

Assets class of GERM ETF is 'Equity'

What is GERM assets under management?

Assets under management of GERM ETF is $9 M

What is GERM average volume?

Average volume of GERM ETF is $2 K

What is GERM domicile?

Domicile of GERM ETF is US

What is GERM expense ratio?

Expense ratio of GERM ETF is 0.68%

What is GERM inception date?

Inception date of GERM ETF is 18 June 2020

What is GERM website?

Website of GERM ETF is null